Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment [PDF]
, 2003 Ravi Bhatia +8 more
openalex +1 more source
New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib. [PDF]
Arch Endocrinol MetabSalimova D +4 more
europepmc +1 more source
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]
, 2008 Jimenez, Sergio A., Rosenbloom, Joel
core +1 more source
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib [PDF]
, 2003 Barbara Waßmann +17 more
openalex +1 more source
Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis. [PDF]
Support Care CancerSmit Y +7 more
europepmc +1 more source
Rapidly Evolving Cervical Dermatofibrosarcoma Protuberans With Deep Muscle Infiltration: A Rare and Aggressive Presentation. [PDF]
CureusBouraqqadi O +4 more
europepmc +1 more source
Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report. [PDF]
Am J Case RepHoff FW +11 more
europepmc +1 more source
Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells. [PDF]
Int J Mol SciCarreño-Flórez GP +4 more
europepmc +1 more source
Hair Re-Pigmentation After Nilotinib [PDF]
Turk J HaematolAydın Ö, Turgut M.
europepmc +1 more source
Functional consequence of MDR1 expression on imatinib intracellular concentrations
, 2003 Nicolas Widmer +3 more
openalex +1 more source